Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001423898-25-000005

Director sold 46,463 shares at an average $355.32 ($16,509,032)

  • Director acquired 46,463 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taub Rebecca Director 2025-08-11 Option exercise 10b5-1 +3,200 $9.45 $30,240 464,244 D: show line 1 in the form
Taub Rebecca Director 2025-08-11 Sale 10b5-1 −2,980 $350.18 $1,043,528 461,264 D: show line 2 in the form
Taub Rebecca Director 2025-08-11 Sale 10b5-1 −220 $351.02 $77,225 461,044 D: show line 3 in the form
Taub Rebecca Director 2025-08-12 Option exercise 10b5-1 +43,263 $9.45 $408,835 504,307 D: show line 4 in the form
Taub Rebecca Director 2025-08-12 Sale 10b5-1 −3,580 $350.87 $1,256,127 500,727 D: show line 5 in the form
Taub Rebecca Director 2025-08-12 Sale 10b5-1 −2,870 $351.60 $1,009,091 497,857 D: show line 6 in the form
Taub Rebecca Director 2025-08-12 Sale 10b5-1 −1,175 $352.45 $414,130 496,682 D: show line 7 in the form
Taub Rebecca Director 2025-08-12 Sale 10b5-1 −4,587 $354.04 $1,623,997 492,095 D: show line 8 in the form
Open-market sales · 46,463 sh · avg $355.32 · $16,509,032

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taub Rebecca Director 2025-08-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −3,200 43,263 D: show line 15 in the form
Taub Rebecca Director 2025-08-12 Option exercise · Stock Option (Right to Buy) 10b5-1 −43,263 0 D: show line 16 in the form
Loading xslF345X05/wk-form4_1755120803.xml…